Ophiomics was granted the SME Instrument Phase I grant to conduct a Feasibility study for its HepatoPredict genomic signature for Liver Cancer. Check here for the CORDIS page. This grant will permit Ophiomics to build a business case for HepatoPredict.

Liver Cancer Awareness Month
October marked Liver Cancer Awareness Month, a time to spotlight one of the world’s fastest-growing and deadliest cancers: Over 900,000


